Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

---

Araz M., Soydal Ç., Gündüz P., Kırmızı B. A., Bakırarar B., Sak S., ...More

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, vol.31, no.1, pp.49-56, 2022 (ESCI, Scopus, TRDizin)

• Publication Type: Article / Article
• Volume: 31 Issue: 1
• Publication Date: 2022
• Doi Number: 10.4274/mirt.galenos.2022.59140
• Journal Name: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Page Numbers: pp.49-56
• Keywords: Breast cancer, PET/CT, fluorodeoxyglucose, hormone receptor, CANCER, ESTROGEN, FEATURES, VOLUME, SUV
• Open Archive Collection: AVESIS Open Access Collection
• Ankara University Affiliated: Yes

Abstract

Objectives: This study aimed to investigate the role of preoperative 'fluorine-fluorodeoxyglucose (F-18-FDG) positron emission tomography/ computed tomography (PET/CT) radiomics features and metabolic parameters of primary breast tumors in predicting hormone receptor (HR) positivity.